Inner-City Anti-IgE Therapy for Asthma (ICAC-08)
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms ICATA
- 05 Mar 2018 Results of post hoc analysis assessing the effect of asthma severity on treatment outcomes with Omalizumab presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
- 22 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Mar 2011 Primary endpoint 'Symptoms' has not been met